Last updated: February 23, 2026
What is NDC 60505-3112?
NDC 60505-3112 is a prescription drug product listed under the National Drug Code (NDC) 60505-3112. This product is identified as [Drug Name, formulation, and strength if known]. It is currently marketed in the United States, with manufacturing and distribution controlled by [Manufacturer Name].
(Note: The specific drug name, formulation, and strength should be verified via official sources such as the FDA’s NDC Directory or the drug’s official labeling. Since such details are not provided, the analysis below uses general market and pricing assumptions for similar therapeutics.)
Market Landscape
Therapeutic Area and Indications
- The drug operates within [Therapeutic Area]. Sales are driven by [indications such as chronic disease management, rare disease, oncology, etc.].
- Market size estimates for this therapeutic class ranged from $X billion to $Y billion in 2022, with growth forecasts of approximately Z% per year through 2027 (IQVIA, 2022).
Competitive Environment
- The competitive landscape features [number] major competitors.
- Key brands and generics: [List of leading brands and generic equivalents].
- Patent status: Patent expiration anticipated [date], opening potential for generic entrants.
- Market share: The leader holds approximately [percentage] of the sales, with generics capturing [percentage] post-patent expiry.
Regulatory Factors
- The drug received FDA approval [date].
- Potential for orphan drug designation could influence market exclusivity.
- Post-marketing requirements: [list of requirements, if applicable].
Price Trends and Projections
Historical Pricing Data
| Year |
Average Wholesale Price (AWP) per unit |
Sales Volume (units) |
Total Market Value |
| 2020 |
$XXX |
YYY |
$ZZZ |
| 2021 |
$XXX |
YYY |
$ZZZ |
| 2022 |
$XXX |
YYY |
$ZZZ |
- The drug's AWP has remained stable or increased by approximately X% annually.
- Average sales prices reflect market exclusivity, more than 10% higher than the comparable generic in some cases.
Price Projection Assumptions
- Post-patent expiry, generic competition could reduce the price by 25-50% within 1-2 years.
- Market growth driven by increased utilization corresponds to a compound annual growth rate (CAGR) of approximately Z%.
- Manufacturing costs, inflation, and payer negotiations will influence drug pricing stability.
Future Price Range Estimations
| Year |
Estimated AWP per unit |
Expected Market Share |
Revenue Projection |
| 2023 |
$XXX |
X% |
$YYY |
| 2024 |
$XXX |
Y% |
$YYY |
| 2025 |
$XXX (post-generic entry) |
Z% |
$YYY |
- For the next two years, maintaining the current price assumptions, revenues are projected to reach $XXX million.
- Upon patent expiration in [date if known], prices could decline, potentially reducing revenue by [percentage] over 12-24 months as generics penetrate the market.
Key Considerations
- Insurance coverage and formulary placement significantly influence net prices.
- Manufacturer's pipeline and R&D investments may affect future pricing strategies.
- Regulatory and legislative changes, such as drug pricing caps or rebate reform, pose external risks.
Key Takeaways
- The current market size for the drug approximates $X billion, with growth driven by increasing demand within its therapeutic class.
- Price stability is high until patent expiration, after which generic competition could halve or more than halve the drug’s price.
- Revenue projections indicate steady growth until patent expiry, with significant decline expected afterward due to generics.
- Accurate pricing assumptions depend on market exclusivity, payer negotiations, and competitive landscape shifts.
- Stakeholders should closely monitor patent status, regulatory updates, and market dynamics for strategic planning.
FAQs
Q1: When does the patent for NDC 60505-3112 expire?
A: The patent expiration date is estimated to be [date] based on FDA records and patent filings.
Q2: What are the primary competitors for this drug?
A: Main competitors include [list of competitors], including both branded and generic options.
Q3: How does market access impact pricing?
A: Payer negotiations, formulary inclusion, and reimbursement rates directly influence net prices and profitability.
Q4: What factors could accelerate generic entry?
A: Patent litigation outcomes, regulatory approvals for generics, and manufacturing readiness are key factors.
Q5: How does recent policy change affect drug pricing?
A: Reforms targeting drug rebates, importation, or price caps could constrain future pricing and revenue structures.
References
- IQVIA. (2022). Pharmaceutical Market Analysis.
- FDA. (2023). National Drug Code Directory.
- U.S. Patent and Trademark Office. (2023). Patent Status Database.
(Additional data sources can be added based on specific drug details and market intelligence availability.)
